A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension
Clinical trial NCT05362110 · COMPLETED
Trial details
- NCT number
- NCT05362110
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-16
- Primary completion
- 2023-06-05
- Enrollment
- 361
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.